App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol Be a Pro
Get App
Select Language
Subscription
Specials
Close Ad
SENSEX NIFTY
you are here:

Markets

Live TV
NIFTY 50
11661.90
75.50 (0.65%)
SENSEX
39298.38
246.32 (0.63%)

Concord Drugs Ltd.

BSE: 538965 | NSE: | ISIN: INE858L01010 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info
Moneycontrol Pro TTrade Now Thomson Reuters report
| BSE 14.90 0.00 (0.00%) | |

BSE Live

Oct 17, 16:00
14.90 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
245
10-Day
458
30-Day
278
11

  • Prev. Close

    14.90

  • Open Price

    14.90

14.90

Today’s L/H

14.90
13.50

52 Wk L/H

26.00
14.20

L/U Price Band

15.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    14.90 (109)

  •  VWAP
    14.90

  • Market Depth (17 Oct 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 Total Total 109
     Market Depth
    BUY 0.00
    SELL 109.00
    0%
    0%

NSE Live

(%)
Volume
No Data Available

  • Prev. Close

  • Open Price

Today’s L/H

52 Wk L/H

L/U Price Band

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

  • VWAP
    Series:
  • DELIVERY AVERAGES
    3-Day
    %
    5-Day
    %
    8-Day
    %
    Deliverables
    %
  • SMA
Concord Drugs is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      13.03
    • P/E
      31.7
    • Book Value (Rs)
      27.49
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      27.62
    • EPS (TTM)
      0.47
    • P/C
      6.13
    • Price/Book
      0.54
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      13.03
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      27.62
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
Get Historical Stock Prices
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD
POST

Action in Concord Drugs Ltd.

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 13.50 on BSE

    Oct 04, 10:40

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 14.20 on BSE

    Oct 03, 11:30

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 14.50 on BSE

    Oct 01, 11:40

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 15.30 on BSE

    Sep 30, 10:22

  • AGM/EGM

    Concord Drugs AGM on Sep 30, 2019, Announcement date: Aug 14, 2019

    Sep 29, 11:00

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 15.30 on BSE

    Sep 27, 13:10

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 15.35 on BSE

    Sep 23, 12:44

  • Only Sellers

    Only Sellers in Concord Drugs on BSE

    Sep 17, 15:10

  • Technicals

    Concord Drugs closes above 30-Day Moving Average of 19.93 today.

    Aug 26

  • 52 Week Low

    Concord Drugs has hit 52wk low of Rs 15.60 on BSE

    Aug 19, 09:32

  • Only Sellers

    Only Sellers in Concord Drugs on BSE

    Jul 08, 15:05

  • Technicals

    Concord Drugs closes above 150-Day Moving Average of 21.87 today.

    Jul 01

  • Only Sellers

    Only Sellers in Concord Drugs on BSE

    Jul 01, 11:30

  • Technicals

    Concord Drugs closes above its 30-Day,50-Day,150-Day Moving Average today.

    Jun 17

  • Technicals

    Concord Drugs closes above 30-Day,50-Day Moving Average today.

    Jan 29

  • Technicals

    Concord Drugs closes above 30-Day Moving Average of 23.51 today.

    Dec 19

  • Technicals

    Concord Drugs closes above its 30-Day,50-Day,150-Day Moving Average today.

    Dec 14

  • Only Sellers

    Only Sellers in Concord Drugs on BSE

    Dec 12, 11:20

  • Views

    Buy CONCOR; target of Rs 800: Dolat Capital

    Dec 10, 17:00
  • AGM/EGM

    Concord Drugs AGM on Sep 29, 2018, Announcement date: Aug 16, 2018

    Sep 28, 11:00

News & Videos

Stocks in the news: PNB, Bank of Baroda, Cadila, NBCC, BPCL, SCI, CG Power, PNB Housing

Stocks in the news: PNB, Bank of Baroda, Cadila, NBCC, BPCL, SCI, CG Power, PNB Housing

Business | Earnings | Management Interviews
View More

News across the web

Data not available
Data not available

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Jun 2019 Mar 2019 Dec 2018 Sep 2018 Jun 2018
Net Sales 13.31 14.34 9.21 11.49 13.03
Other Income 0.03 0.02 0.02 0.02 0.03
PBDIT 0.95 0.70 0.98 0.97 0.99
Net Profit 0.13 0.21 0.04 0.04 0.13

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 7.86 7.86
Networth 23.15 19.32
Total Debt 9.83 12.41
Net Block 12.14 13.51
Investments 0.00 0.00
Total Assets 32.98 31.75

Historical Prices

On
 Current Price %Gain / Loss
Open Price 24.65 14.90
-39.55
High Price 24.65 14.90
-39.55
Low Price 23.00 14.90
-35.22
Close Price 23.00 14.90
-35.22
Volume 68 11
-83.82
On
 Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11661.90 75.50 0.65
SENSEX 39298.38 246.32 0.63
NIFTY BANK 29120.25 130.80 0.45
NIFTY IT 15410.10 128.20 0.84
S&P BSE Smallcap 13126.83 212.74 1.65
View More
Index Price Change %Chg
Nasdaq (Oct 19) 8,089.54 -67.31 -0.83
DAX (Oct 18) 12,633.60 -21.35 -0.17
CAC (Oct 18) 5,636.25 -36.82 -0.65
FTSE (Oct 18) 7,150.57 -31.75 -0.44
SGX Nifty (Oct 19) 11,669.50 -12.00 -0.10
View More

CORPORATE ACTION

Date Agenda
Aug 14, 2019 Quarterly Results
May 30, 2019 Audited Results
Feb 14, 2019 Quarterly Results
Nov 14, 2018 Quarterly Results
Type Dividend% Ex-Dividend date
No Dividends Information is available for Concord Drugs
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Concord Drugs
Old FV New FV Ex-Split
No Splits Information is available for Concord Drugs
Ratio Premium Ex-Bonus
No Rights Information is available for Concord Drugs
Date Agenda
Sep 30, 2019 -
Sep 29, 2018 -
Aug 24, 2018 -
Sep 29, 2017 -
Sep 29, 2016 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone March 2019 December 2018 September 2018 March 2018
Promoters 38.93 38.9 38.9 38.9
Pledged 0 0 0 0
FII/FPI 0 0 0 0
Total DII 1.6 1.35 1.43 1.87
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 1.6 1.35 1.43 1.87
Others 59.47 59.75 59.66 59.23
Total 100 100 99.99 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Concord Drugs 14.90 0.00 26.00 13.50 13.03 48.08 0.41
Sun Pharma 401.40 0.00 616.50 350.40 96309.31 10,303.21 816.60
Divis Labs 1738.70 0.86 1768.80 1214.25 46157.02 4,879.66 1,332.65
Dr Reddys Labs 2723.80 -0.10 2965.20 2065.30 45254.78 10,625.50 1,277.30
Ranbaxy Labs 859.80 0.00 869.70 371.50 36598.55 6,864.94 -879.00

COMPANY OVERVIEW

Concord Drugs Limited was created in 1995 to manufacture and market innovative pharmaceutical products. Concord `s three core product areas are generics, branded and specialty pharmaceuticals. The Company ranks among the top generics suppliers in India. Through an aggressive licensing and acquisition program, Concord is rapidly expanding in branded and specialty pharmaceuticals. With a rigorous focus on growth, Concord develops, manufactures and markets more than 200 prescription and over-the-counter pharmaceutical products

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • S Nagi Reddy

      Chairman & Wholetime Director

    • T Narsimha Reddy

      Managing Director

    • S Koni Reddy

      Executive Director & CFO

    • K Ramachandra Reddy

      Non Executive Director

    • P Venkatram Reddy

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Concord Drugs Ltd.

Concord Drugs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 538965.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Concord Drugs Stock Price | Concord Drugs Stock Quote | Concord Drugs Results | Concord Drugs News | View All Related Searches
Sections
Desktop Version »
Follow us on
Available On
PCI DSS Compliant
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.